Table 1.
Organisma | Transcriptsb | Modeled targetsc | Similard | Exacte |
---|---|---|---|---|
Cryptosporidium hominis | 3,886 | 666 | 20 | 13 |
Cryptosporidium parvum | 3,806 | 742 | 24 | 13 |
| ||||
Leishmania major | 8,274 | 1,409 | 43 | 20 |
| ||||
Mycobacterium leprae | 1,605 | 893 | 25 | 6 |
| ||||
Mycobacterium tuberculosis | 3,991 | 1,608 | 30 | 10 |
| ||||
Plasmodium falciparum | 5,363 | 818 | 28 | 13 |
| ||||
Plasmodium vivax | 5,342 | 822 | 24 | 13 |
| ||||
Toxoplasma gondii | 7,793 | 300 | 13 | 6 |
| ||||
Trypanosoma cruzi | 19,607 | 3,070 | 51 | 28 |
| ||||
Trypanosoma brucei | 9,210 | 1,386 | 39 | 21 |
| ||||
Total | 68,877 | 11,714 | 297 | 143 |
Organisms in bold are included in the WHO Tropical Disease portfolio.
Number of transcripts in each genome.
Number of targets with at least one domain accurately modeled (i.e., MODPIPE quality score of at least 1.0).
Number of modeled targets with at least one predicted binding site for a molecule with a Tanimoto score9 of at least 0.9 to a drug in DrugBank10.
Number of modeled targets with at least one predicted binding site for a molecule in DrugBank.